that Inovio has a $3.5 million contract with DOD to comparatively evaluate the efficacy of currently used vaccination techniques (pneumatic syringe) with electorporesis. If positive results are achieved there, the entire procedure for preventive immunizations for armed forces personnel, Peace Corps volunteers, CDC field agents, etc., etc. will change dramatically. I know that these studies and the data are confidential between Inovio and DOD, but that one could be a major bell ringer. I think that DOD solicited the trial like FDA solicited INSM to do the NTM trial with Arikace. We shall see.
I was not familiar with this one as I bought my original shares in August, after it's first spike above $3.00 on a recommendation from a serious biotech friend. He mentioned it in June when it was $0.62 DUH!!!
What are the milestone payments beyond the $3.5 million if I might ask?
Now that INO is optionable, I'm getting serious about the company, (I like what I am seeing so far.) On March 10th I sold a rather large pile of April $2.50 puts and have bought some August calls at all three strikes plus added to my early long position. All good so far...